Pivmecillinam
Paul G. Auwaerter, M.D., Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Chalk Sharpless Chalk, Pharm.D., BCPPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- FDA approved April 2024, but it is not yet available commercially.
- Treatment of female patients 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of urinary tract infections for susceptible pathogens
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved